Latest Comments on Lets Be Reasonable's Articles

1. Culann Smith on Dendreon: An Even Better Risk vs. Reward Scenario : i subscribe to this more »
2. Wall Diver on Dendreon: An Even Better Risk vs. Reward Scenario : I see a lot of articles in the press that discuss the 4.5-month... more »
3. sangell3 on Dendreon: Revisiting the Risk/Reward Scenario : Indeed, we are talking a acne, toenail fungus or in the case of... more »
4. The Kennel on Dendreon: Revisiting the Risk/Reward Scenario : We rec'ced Dendreon back on 10 Jan 07 (stock closed at $4.01) and... more »
5. dennisslosser on Dendreon: Revisiting the Risk/Reward Scenario : Still a believer that dndn should bi in 50-70 range come end of may more »
6. H S on Dendreon: Revisiting the Risk/Reward Scenario : Just my 2 cents: JMP's target price is $24 assuming 50%... more »
7. Wall Diver on Dendreon: Revisiting the Risk/Reward Scenario : While many on Wall Street still believe that the FDA won't approve... more »
8. mouton29 on Dendreon: Don't Forget About Risk vs. Reward: The point is clear enough but since this argument about "changing... more »
9. CrossProfit_ on Dendreon: Don't Forget About Risk vs. Reward: Agree. CrossProfit more »
10. Keith Rettig on Dendreon: Don't Forget About Risk vs. Reward: It should be clearly noted that the FDA did NOT change the... more »
11. Wall Diver on Dendreon: Don't Forget About Risk vs. Reward: I should have added in my comment above that the placebo patients... more »
12. Wall Diver on Dendreon: Don't Forget About Risk vs. Reward: Instead of wondering why the FDA reworded the original question,... more »
13. Echo To All on Dendreon: Don't Forget About Risk vs. Reward: Risks to reward? I have written a piece painting the realistic... more »